Building access to the Regenstrief Institute is currently restricted. More on our coronavirus precautions.
See our coronavirus precautions.

Regenstrief Institute faculty member Shaun Grannis, M.D., participated in a private workshop in Washington, D.C. on considerations and potential best practices for large-scale curation of real-world data that could support regulatory decision-making. The panel was convened under a cooperative agreement between the U.S. Food and Drug Administration and Duke University Robert J. Margolis, M.D., Center for Health Policy. 

In the coming years, opportunities will emerge to make better use of real-world data within the FDA’s regulatory framework. More consistent use of that data can improve the efficiency of traditional randomized control trials, and there may be opportunities to leverage that data and evidence in support of supplemental approval or labeling actions. FDA officials are asking for the input of stakeholders from across the country to advance policy development related to the regulatory acceptability of real-word evidence. This workshop gathered perspective and explored best practices for the data curation process.

Dr. Grannis, who is the director for the Regenstrief Center for Biomedical Informatics and an associate professor at the Indiana University School of Medicine, shared his expertise on data integration. He spoke about the best strategies to link data together and the best methods to measure matching accuracy. Dr. Grannis’ research is focused on improving discovery and decision support by developing, testing and implementing innovative approaches for data integration, patient matching, predictive modeling and other novel data science use cases.

From here, the FDA will evaluate the input from the workshop and decide how it will influence future policies and practice. The agency is working to meet real-world evidence milestones as established in the 21st Century Cures Act and the sixth Prescription Drug User Fee Act.

MEDIA CONTACT:

John Erickson
Regenstrief Institute
jorerick@regenstrief.org
(317) 274-9062

Related News

May 07, 2021 • News
Regenstrief researcher wins American Board of Internal Medicine Foundation award for paper
Regenstrief Institute Research Scientist Richard Frankel, PhD, won the 2020 John A. Benson Jr., M.D., Professionalism Article Prize from the American Board of Internal Medicine (ABIM) Foundation. The award recognizes peer-reviewed journal articles that document the impact of medical professionalism on improving healthcare.   Dr. Frankel was the senior author on the paper “If your feelings were hurt, I’m sorry…” How…
Continue Reading >
May 07, 2021 • News
A bridge from classroom to providing actual patient care: A study of the Regenstrief tEMR
Anonymized real-world platform gives learners realistic experience with health IT As electronic medical records (EMRs) are increasingly used across the United States, the next generation of physicians, nurses, social workers, pharmacists and other clinicians need to acquire new knowledge and competencies related to use of EMRs early in their clinical education. But training is not…
Continue Reading >